

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.09404322 |
| 2 | DNA deamination (GO:0045006) | 5.07191839 |
| 3 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.90504613 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.49171179 |
| 5 | sequestering of actin monomers (GO:0042989) | 4.32070933 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 4.16267162 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.16267162 |
| 8 | viral transcription (GO:0019083) | 4.15393956 |
| 9 | barbed-end actin filament capping (GO:0051016) | 4.08696244 |
| 10 | translational termination (GO:0006415) | 3.98047557 |
| 11 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.96942213 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 3.94315492 |
| 13 | translational elongation (GO:0006414) | 3.91461701 |
| 14 | regulation of protein heterodimerization activity (GO:0043497) | 3.84480728 |
| 15 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.73488432 |
| 16 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.73488432 |
| 17 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.73197743 |
| 18 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.67592147 |
| 19 | respiratory electron transport chain (GO:0022904) | 3.65840937 |
| 20 | protein targeting to mitochondrion (GO:0006626) | 3.65474436 |
| 21 | pentose-phosphate shunt (GO:0006098) | 3.62569288 |
| 22 | formation of translation preinitiation complex (GO:0001731) | 3.56295278 |
| 23 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.55040986 |
| 24 | protein targeting to ER (GO:0045047) | 3.54541740 |
| 25 | electron transport chain (GO:0022900) | 3.53910599 |
| 26 | cotranslational protein targeting to membrane (GO:0006613) | 3.49882893 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.49599094 |
| 28 | regulation of early endosome to late endosome transport (GO:2000641) | 3.49495242 |
| 29 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.48213521 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.46680200 |
| 31 | purine-containing compound salvage (GO:0043101) | 3.46400075 |
| 32 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.46206271 |
| 33 | actin nucleation (GO:0045010) | 3.45087521 |
| 34 | nuclear envelope reassembly (GO:0031468) | 3.44355499 |
| 35 | mitotic nuclear envelope reassembly (GO:0007084) | 3.44355499 |
| 36 | viral life cycle (GO:0019058) | 3.42248847 |
| 37 | establishment of protein localization to mitochondrion (GO:0072655) | 3.41263131 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.41126929 |
| 39 | protein localization to endoplasmic reticulum (GO:0070972) | 3.39184902 |
| 40 | protein neddylation (GO:0045116) | 3.37418017 |
| 41 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.34522915 |
| 42 | galactose catabolic process (GO:0019388) | 3.32690482 |
| 43 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.30522538 |
| 44 | establishment of viral latency (GO:0019043) | 3.29101589 |
| 45 | cellular protein complex disassembly (GO:0043624) | 3.27087576 |
| 46 | translational initiation (GO:0006413) | 3.26306656 |
| 47 | proteasome assembly (GO:0043248) | 3.25269442 |
| 48 | T cell apoptotic process (GO:0070231) | 3.25005432 |
| 49 | nucleoside salvage (GO:0043174) | 3.19625544 |
| 50 | purine nucleotide salvage (GO:0032261) | 3.19289132 |
| 51 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.16625170 |
| 52 | protein localization to mitochondrion (GO:0070585) | 3.16584500 |
| 53 | NADPH regeneration (GO:0006740) | 3.15746286 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.14126493 |
| 55 | regulation of mitochondrial translation (GO:0070129) | 3.13875516 |
| 56 | establishment of integrated proviral latency (GO:0075713) | 3.13630404 |
| 57 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.10917774 |
| 58 | negative regulation of ligase activity (GO:0051352) | 3.10917774 |
| 59 | GTP biosynthetic process (GO:0006183) | 3.09994216 |
| 60 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.09887878 |
| 61 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.08875002 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.06847849 |
| 63 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.04269467 |
| 64 | UV protection (GO:0009650) | 3.03958525 |
| 65 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.03768251 |
| 66 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.01796332 |
| 67 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.00406236 |
| 68 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.00227372 |
| 69 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99539503 |
| 70 | protein insertion into membrane (GO:0051205) | 2.99030012 |
| 71 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.97342433 |
| 72 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.96797894 |
| 73 | UTP biosynthetic process (GO:0006228) | 2.95999484 |
| 74 | protein complex biogenesis (GO:0070271) | 2.95137405 |
| 75 | maturation of SSU-rRNA (GO:0030490) | 2.93363401 |
| 76 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.93226156 |
| 77 | endosome to pigment granule transport (GO:0043485) | 2.91479659 |
| 78 | endosome to melanosome transport (GO:0035646) | 2.91479659 |
| 79 | positive regulation of lamellipodium assembly (GO:0010592) | 2.90390532 |
| 80 | cellular component biogenesis (GO:0044085) | 2.89812953 |
| 81 | protein complex disassembly (GO:0043241) | 2.89724545 |
| 82 | response to interferon-beta (GO:0035456) | 2.88022637 |
| 83 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.87097604 |
| 84 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.87077722 |
| 85 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.87077722 |
| 86 | protein maturation by protein folding (GO:0022417) | 2.86950117 |
| 87 | negative regulation of microtubule polymerization (GO:0031115) | 2.86382814 |
| 88 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.85928577 |
| 89 | deoxyribonucleotide catabolic process (GO:0009264) | 2.84843137 |
| 90 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.84674069 |
| 91 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.84674069 |
| 92 | pentose metabolic process (GO:0019321) | 2.84521369 |
| 93 | protein retention in ER lumen (GO:0006621) | 2.84298553 |
| 94 | deoxyribose phosphate catabolic process (GO:0046386) | 2.83914085 |
| 95 | regulation of mitochondrial membrane potential (GO:0051881) | 2.82677395 |
| 96 | termination of RNA polymerase III transcription (GO:0006386) | 2.81397858 |
| 97 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.81397858 |
| 98 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.81102767 |
| 99 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.81102767 |
| 100 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.81102767 |
| 101 | heme biosynthetic process (GO:0006783) | 2.80713326 |
| 102 | ribosomal small subunit biogenesis (GO:0042274) | 2.80497154 |
| 103 | macromolecular complex disassembly (GO:0032984) | 2.80248353 |
| 104 | COPI coating of Golgi vesicle (GO:0048205) | 2.80223129 |
| 105 | Golgi transport vesicle coating (GO:0048200) | 2.80223129 |
| 106 | translation (GO:0006412) | 2.79051319 |
| 107 | regulation of translational termination (GO:0006449) | 2.78876674 |
| 108 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.77892532 |
| 109 | pinocytosis (GO:0006907) | 2.75583062 |
| 110 | negative regulation of mitochondrion organization (GO:0010823) | 2.74966447 |
| 111 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.74225679 |
| 112 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.74225679 |
| 113 | cellular response to zinc ion (GO:0071294) | 2.73989377 |
| 114 | lymphocyte apoptotic process (GO:0070227) | 2.73885369 |
| 115 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.73216774 |
| 116 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.72582133 |
| 117 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.72370996 |
| 118 | regulation of metalloenzyme activity (GO:0048552) | 2.70017297 |
| 119 | oxidative phosphorylation (GO:0006119) | 2.69447664 |
| 120 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69222931 |
| 121 | GDP-mannose metabolic process (GO:0019673) | 2.68106992 |
| 122 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.66092077 |
| 123 | NADH dehydrogenase complex assembly (GO:0010257) | 2.65971083 |
| 124 | de novo protein folding (GO:0006458) | 2.63914851 |
| 125 | de novo posttranslational protein folding (GO:0051084) | 2.63642800 |
| 126 | nucleotide salvage (GO:0043173) | 2.63247656 |
| 127 | pyrimidine nucleoside salvage (GO:0043097) | 2.63096149 |
| 128 | pyrimidine-containing compound salvage (GO:0008655) | 2.63096149 |
| 129 | positive regulation of ligase activity (GO:0051351) | 2.61106462 |
| 130 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.59286287 |
| 131 | DNA strand elongation (GO:0022616) | 2.56994655 |
| 132 | protein targeting to membrane (GO:0006612) | 2.55974936 |
| 133 | negative regulation of cell size (GO:0045792) | 2.55127059 |
| 134 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.54228998 |
| 135 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.53743734 |
| 136 | immunoglobulin mediated immune response (GO:0016064) | 2.52949256 |
| 137 | * antigen processing and presentation of exogenous peptide antigen (GO:0002478) | 2.49897739 |
| 138 | * antigen processing and presentation of exogenous antigen (GO:0019884) | 2.49367591 |
| 139 | ribosomal large subunit biogenesis (GO:0042273) | 2.48711865 |
| 140 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.48036126 |
| 141 | metallo-sulfur cluster assembly (GO:0031163) | 2.47185405 |
| 142 | iron-sulfur cluster assembly (GO:0016226) | 2.47185405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.43468443 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.74298599 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.63165270 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.41807666 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.28609975 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.24571930 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.19926434 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16282940 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.13732260 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.11270692 |
| 11 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.05639197 |
| 12 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.96223657 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91267317 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90379704 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89172129 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.88824167 |
| 17 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.85868743 |
| 18 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85304138 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.83895812 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83094421 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76795757 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.75757602 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.74254829 |
| 24 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67536573 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67473858 |
| 26 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.66110182 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.65846329 |
| 28 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.64620112 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64555093 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63022923 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62037098 |
| 32 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.61627406 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.61309274 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57536289 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56155785 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55789714 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.52889509 |
| 38 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.49837452 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47658874 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46981061 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45623224 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44004321 |
| 43 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43999389 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43972695 |
| 45 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.43322509 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42963010 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40274905 |
| 48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.40068025 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.40041511 |
| 50 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.39589871 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39074165 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.37519564 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36297525 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36016544 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.34730733 |
| 56 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33709837 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33667625 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33617044 |
| 59 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33189022 |
| 60 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.32328964 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32033839 |
| 62 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31640215 |
| 63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30586088 |
| 64 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.29986622 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29689343 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27042282 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27036928 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26479301 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.24905404 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24368008 |
| 71 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23215306 |
| 72 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23048692 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.22935215 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22445711 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.22241716 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20684175 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.20503601 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20002652 |
| 79 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18764404 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18452891 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17439544 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17187882 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16500471 |
| 84 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16404032 |
| 85 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16385200 |
| 86 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15962347 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15469658 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15289783 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14490624 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14222667 |
| 91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.13800364 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.13622144 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13460120 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12891388 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11915768 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11630071 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11367476 |
| 98 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11034052 |
| 99 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10870154 |
| 100 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.10618058 |
| 101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10306186 |
| 102 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.10253786 |
| 103 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09925946 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09449036 |
| 105 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09404105 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09310054 |
| 107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09122476 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08766191 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.08589310 |
| 110 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08373268 |
| 111 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08370608 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08351374 |
| 113 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07905102 |
| 114 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.07389810 |
| 115 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07177822 |
| 116 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06598080 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06576703 |
| 118 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06204286 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05329705 |
| 120 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04900623 |
| 121 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04696766 |
| 122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03738812 |
| 123 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00894765 |
| 124 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99469096 |
| 125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.98712665 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98214411 |
| 127 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.95169075 |
| 128 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94952225 |
| 129 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94468478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 3.03261552 |
| 2 | MP0003436_decreased_susceptibility_to | 2.92678132 |
| 3 | MP0009379_abnormal_foot_pigmentation | 2.88126607 |
| 4 | MP0005257_abnormal_intraocular_pressure | 2.87315472 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.86215866 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.76160231 |
| 7 | MP0003303_peritoneal_inflammation | 2.74993485 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.68077138 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.66078631 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.61292727 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.59669390 |
| 12 | MP0008260_abnormal_autophagy | 2.46444976 |
| 13 | MP0003186_abnormal_redox_activity | 2.36172538 |
| 14 | MP0004858_abnormal_nervous_system | 2.30556378 |
| 15 | MP0001542_abnormal_bone_strength | 2.29208547 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.27569164 |
| 17 | MP0009785_altered_susceptibility_to | 2.27196420 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.12535611 |
| 19 | MP0010030_abnormal_orbit_morphology | 2.10915668 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.08761768 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.07204906 |
| 22 | MP0000685_abnormal_immune_system | 2.04381859 |
| 23 | MP0005025_abnormal_response_to | 1.98890641 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.94592632 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.94592632 |
| 26 | MP0006054_spinal_hemorrhage | 1.93841652 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.92964861 |
| 28 | MP0005451_abnormal_body_composition | 1.86351323 |
| 29 | MP0002419_abnormal_innate_immunity | 1.83994989 |
| 30 | MP0004957_abnormal_blastocyst_morpholog | 1.81694780 |
| 31 | MP0000750_abnormal_muscle_regeneration | 1.78418912 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.75225307 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.69436655 |
| 34 | MP0000858_altered_metastatic_potential | 1.68432018 |
| 35 | MP0005165_increased_susceptibility_to | 1.66485999 |
| 36 | MP0000604_amyloidosis | 1.66321080 |
| 37 | MP0004510_myositis | 1.64002642 |
| 38 | MP0005083_abnormal_biliary_tract | 1.63740203 |
| 39 | MP0003329_amyloid_beta_deposits | 1.62518696 |
| 40 | MP0006082_CNS_inflammation | 1.60874120 |
| 41 | MP0002398_abnormal_bone_marrow | 1.60370013 |
| 42 | MP0001819_abnormal_immune_cell | 1.60072783 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.60054824 |
| 44 | MP0002723_abnormal_immune_serum | 1.58061431 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.58041619 |
| 46 | MP0005501_abnormal_skin_physiology | 1.55906060 |
| 47 | MP0001853_heart_inflammation | 1.54283027 |
| 48 | MP0004859_abnormal_synaptic_plasticity | 1.53363270 |
| 49 | MP0000358_abnormal_cell_content/ | 1.53040789 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.51655355 |
| 51 | MP0000343_altered_response_to | 1.46724613 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.44525176 |
| 53 | MP0002722_abnormal_immune_system | 1.44217250 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.43919976 |
| 55 | MP0000490_abnormal_crypts_of | 1.43838051 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.43699808 |
| 57 | MP0008469_abnormal_protein_level | 1.43626204 |
| 58 | MP0002405_respiratory_system_inflammati | 1.42123153 |
| 59 | MP0003075_altered_response_to | 1.42090779 |
| 60 | MP0009053_abnormal_anal_canal | 1.42062864 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.41959623 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.40376782 |
| 63 | MP0005671_abnormal_response_to | 1.40349762 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.40081574 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.40041391 |
| 66 | MP0003279_aneurysm | 1.39919072 |
| 67 | MP0002429_abnormal_blood_cell | 1.37196615 |
| 68 | MP0001790_abnormal_immune_system | 1.35840657 |
| 69 | MP0005387_immune_system_phenotype | 1.35840657 |
| 70 | MP0003786_premature_aging | 1.34884419 |
| 71 | MP0001800_abnormal_humoral_immune | 1.33991580 |
| 72 | MP0000716_abnormal_immune_system | 1.33660946 |
| 73 | MP0001849_ear_inflammation | 1.30554459 |
| 74 | MP0004233_abnormal_muscle_weight | 1.29157952 |
| 75 | MP0001968_abnormal_touch/_nociception | 1.29074700 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.28614754 |
| 77 | MP0003724_increased_susceptibility_to | 1.27985804 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.27779980 |
| 79 | MP0003111_abnormal_nucleus_morphology | 1.25804846 |
| 80 | MP0003866_abnormal_defecation | 1.25637739 |
| 81 | MP0004272_abnormal_basement_membrane | 1.25478379 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 1.22784653 |
| 83 | MP0003763_abnormal_thymus_physiology | 1.22365353 |
| 84 | MP0002736_abnormal_nociception_after | 1.21698658 |
| 85 | MP0003077_abnormal_cell_cycle | 1.21086386 |
| 86 | MP0005166_decreased_susceptibility_to | 1.19709803 |
| 87 | MP0002396_abnormal_hematopoietic_system | 1.19144448 |
| 88 | MP0001727_abnormal_embryo_implantation | 1.17232481 |
| 89 | MP0010155_abnormal_intestine_physiology | 1.16607566 |
| 90 | MP0001348_abnormal_lacrimal_gland | 1.13086309 |
| 91 | MP0001905_abnormal_dopamine_level | 1.12184892 |
| 92 | MP0004947_skin_inflammation | 1.12064693 |
| 93 | MP0003300_gastrointestinal_ulcer | 1.08018475 |
| 94 | MP0002019_abnormal_tumor_incidence | 1.07545280 |
| 95 | MP0010307_abnormal_tumor_latency | 1.07405696 |
| 96 | MP0003950_abnormal_plasma_membrane | 1.07262251 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06573703 |
| 98 | MP0003566_abnormal_cell_adhesion | 1.06306667 |
| 99 | MP0009764_decreased_sensitivity_to | 1.06037052 |
| 100 | MP0005023_abnormal_wound_healing | 1.04087646 |
| 101 | MP0002733_abnormal_thermal_nociception | 1.03679847 |
| 102 | MP0002796_impaired_skin_barrier | 1.03348278 |
| 103 | MP0003448_altered_tumor_morphology | 1.03193308 |
| 104 | MP0002089_abnormal_postnatal_growth/wei | 1.02543280 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 1.02198896 |
| 106 | MP0000313_abnormal_cell_death | 0.99127269 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.98996389 |
| 108 | MP0002060_abnormal_skin_morphology | 0.97135186 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.96159061 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.95313484 |
| 111 | MP0005193_abnormal_anterior_eye | 0.94788927 |
| 112 | MP0003123_paternal_imprinting | 0.94333000 |
| 113 | MP0008873_increased_physiological_sensi | 0.92549078 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.91571718 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.91531527 |
| 116 | MP0001756_abnormal_urination | 0.91237480 |
| 117 | MP0005310_abnormal_salivary_gland | 0.91169651 |
| 118 | MP0003315_abnormal_perineum_morphology | 0.90659750 |
| 119 | MP0003879_abnormal_hair_cell | 0.90230178 |
| 120 | MP0005670_abnormal_white_adipose | 0.89228309 |
| 121 | MP0009278_abnormal_bone_marrow | 0.88854931 |
| 122 | MP0003941_abnormal_skin_development | 0.87840438 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.87412873 |
| 124 | MP0009643_abnormal_urine_homeostasis | 0.87385994 |
| 125 | MP0001663_abnormal_digestive_system | 0.86840194 |
| 126 | MP0000598_abnormal_liver_morphology | 0.84171668 |
| 127 | MP0005390_skeleton_phenotype | 0.83614391 |
| 128 | MP0004811_abnormal_neuron_physiology | 0.83331138 |
| 129 | MP0004147_increased_porphyrin_level | 0.82791401 |
| 130 | MP0005408_hypopigmentation | 0.81903581 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.80967399 |
| 132 | MP0008932_abnormal_embryonic_tissue | 0.80893783 |
| 133 | MP0006035_abnormal_mitochondrial_morpho | 0.79140338 |
| 134 | MP0001243_abnormal_dermal_layer | 0.78938663 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.76296737 |
| 136 | MP0001881_abnormal_mammary_gland | 0.75593841 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.75139419 |
| 138 | MP0008874_decreased_physiological_sensi | 0.72316864 |
| 139 | MP0001216_abnormal_epidermal_layer | 0.70544278 |
| 140 | MP0002998_abnormal_bone_remodeling | 0.69525207 |
| 141 | MP0010771_integument_phenotype | 0.68216584 |
| 142 | MP0000749_muscle_degeneration | 0.67482901 |
| 143 | MP0005330_cardiomyopathy | 0.66502231 |
| 144 | MP0002163_abnormal_gland_morphology | 0.65476062 |
| 145 | MP0000681_abnormal_thyroid_gland | 0.65113182 |
| 146 | MP0005384_cellular_phenotype | 0.64905700 |
| 147 | MP0002090_abnormal_vision | 0.64254213 |
| 148 | MP0008004_abnormal_stomach_pH | 0.60863111 |
| 149 | MP0003795_abnormal_bone_structure | 0.60523785 |
| 150 | MP0005508_abnormal_skeleton_morphology | 0.59974748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.19943122 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.91486915 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 3.87130970 |
| 4 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.83343804 |
| 5 | Acute encephalopathy (HP:0006846) | 3.58296240 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.53455002 |
| 7 | Increased CSF lactate (HP:0002490) | 3.29729977 |
| 8 | Renal Fanconi syndrome (HP:0001994) | 3.29549632 |
| 9 | Premature rupture of membranes (HP:0001788) | 3.27087067 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.25571220 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.13143020 |
| 12 | Rough bone trabeculation (HP:0100670) | 3.03854426 |
| 13 | Petechiae (HP:0000967) | 3.02781769 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 2.98163216 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.96152044 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.96152044 |
| 17 | Myokymia (HP:0002411) | 2.96096140 |
| 18 | Recurrent abscess formation (HP:0002722) | 2.95963949 |
| 19 | Prolonged neonatal jaundice (HP:0006579) | 2.95202835 |
| 20 | Increased intramyocellular lipid droplets (HP:0012240) | 2.92640367 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 2.91935338 |
| 22 | Thrombocytosis (HP:0001894) | 2.87899617 |
| 23 | Diminished motivation (HP:0000745) | 2.78529630 |
| 24 | Poor head control (HP:0002421) | 2.76151644 |
| 25 | Dysostosis multiplex (HP:0000943) | 2.76048542 |
| 26 | Vertebral compression fractures (HP:0002953) | 2.72684413 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.64298374 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.61969950 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.60432293 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.60432293 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.60432293 |
| 32 | Multiple enchondromatosis (HP:0005701) | 2.60090003 |
| 33 | Increased muscle lipid content (HP:0009058) | 2.58234097 |
| 34 | Cerebral edema (HP:0002181) | 2.58085341 |
| 35 | Entropion (HP:0000621) | 2.54725343 |
| 36 | Respiratory failure (HP:0002878) | 2.53752466 |
| 37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.53637932 |
| 38 | Upper motor neuron abnormality (HP:0002127) | 2.53385356 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.52790759 |
| 40 | Hypercortisolism (HP:0001578) | 2.52469597 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.49935327 |
| 42 | Progressive neurologic deterioration (HP:0002344) | 2.48748161 |
| 43 | Abnormal trabecular bone morphology (HP:0100671) | 2.47339210 |
| 44 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.46183419 |
| 45 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.44322755 |
| 46 | Lactic acidosis (HP:0003128) | 2.42044521 |
| 47 | Loss of speech (HP:0002371) | 2.41849644 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40243223 |
| 49 | Exercise intolerance (HP:0003546) | 2.37723495 |
| 50 | Microretrognathia (HP:0000308) | 2.37567129 |
| 51 | Apathy (HP:0000741) | 2.33816490 |
| 52 | Abnormality of the motor neurons (HP:0002450) | 2.33224618 |
| 53 | Abnormal neuron morphology (HP:0012757) | 2.33224618 |
| 54 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.31172176 |
| 55 | Personality changes (HP:0000751) | 2.29500731 |
| 56 | Trismus (HP:0000211) | 2.29140611 |
| 57 | Cholecystitis (HP:0001082) | 2.28647371 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.28647371 |
| 59 | Pallor (HP:0000980) | 2.26359130 |
| 60 | Cellulitis (HP:0100658) | 2.26000262 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25002884 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.23703461 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.22518016 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22433910 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.22433910 |
| 66 | Hypokinesia (HP:0002375) | 2.22071323 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.21952846 |
| 68 | Testicular atrophy (HP:0000029) | 2.20306528 |
| 69 | Reticulocytopenia (HP:0001896) | 2.20027364 |
| 70 | Exertional dyspnea (HP:0002875) | 2.19773237 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.19765164 |
| 72 | Progressive muscle weakness (HP:0003323) | 2.19576291 |
| 73 | Aplastic anemia (HP:0001915) | 2.19359774 |
| 74 | Abnormality of the anterior horn cell (HP:0006802) | 2.18253191 |
| 75 | Degeneration of anterior horn cells (HP:0002398) | 2.18253191 |
| 76 | Increased serum lactate (HP:0002151) | 2.17924980 |
| 77 | Nuclear cataract (HP:0100018) | 2.16945157 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.16646166 |
| 79 | Beaking of vertebral bodies (HP:0004568) | 2.16456991 |
| 80 | Distal lower limb muscle weakness (HP:0009053) | 2.15347451 |
| 81 | Increased serum ferritin (HP:0003281) | 2.14210179 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 2.13773016 |
| 83 | Hand muscle atrophy (HP:0009130) | 2.13762472 |
| 84 | Myositis (HP:0100614) | 2.11830040 |
| 85 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.11780581 |
| 86 | Abnormality of the nasal mucosa (HP:0000433) | 2.11198612 |
| 87 | Hypertensive crisis (HP:0100735) | 2.09310699 |
| 88 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07659117 |
| 89 | Urticaria (HP:0001025) | 2.07131958 |
| 90 | Neoplasm of head and neck (HP:0012288) | 2.05564962 |
| 91 | Esophageal neoplasm (HP:0100751) | 2.05564962 |
| 92 | Fasciculations (HP:0002380) | 2.03865518 |
| 93 | Nonimmune hydrops fetalis (HP:0001790) | 2.03692242 |
| 94 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01409004 |
| 95 | Abnormality of reticulocytes (HP:0004312) | 2.00065275 |
| 96 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.99561725 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 1.99103746 |
| 98 | Delusions (HP:0000746) | 1.98489485 |
| 99 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.98362915 |
| 100 | Respiratory difficulties (HP:0002880) | 1.97828576 |
| 101 | Short nail (HP:0001799) | 1.97603914 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97430329 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97430329 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97430329 |
| 105 | Growth hormone excess (HP:0000845) | 1.97008176 |
| 106 | Nasal polyposis (HP:0100582) | 1.96676220 |
| 107 | Abnormality of T cell physiology (HP:0011840) | 1.96264656 |
| 108 | Polygenic inheritance (HP:0010982) | 1.95588534 |
| 109 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95194588 |
| 110 | Amyloidosis (HP:0011034) | 1.93952284 |
| 111 | Opisthotonus (HP:0002179) | 1.93930394 |
| 112 | Peritonitis (HP:0002586) | 1.91974672 |
| 113 | Basal ganglia calcification (HP:0002135) | 1.91408669 |
| 114 | Mutism (HP:0002300) | 1.90387606 |
| 115 | Sparse eyelashes (HP:0000653) | 1.90078419 |
| 116 | Cerebral hypomyelination (HP:0006808) | 1.89996287 |
| 117 | Reticulocytosis (HP:0001923) | 1.88836599 |
| 118 | Axonal loss (HP:0003447) | 1.88502790 |
| 119 | Abnormality of the umbilical cord (HP:0010881) | 1.87172725 |
| 120 | Macrocytic anemia (HP:0001972) | 1.86994142 |
| 121 | Hepatocellular necrosis (HP:0001404) | 1.85170294 |
| 122 | Large eyes (HP:0001090) | 1.84865060 |
| 123 | Achilles tendon contracture (HP:0001771) | 1.84219833 |
| 124 | Myocardial infarction (HP:0001658) | 1.83976513 |
| 125 | Recurrent fungal infections (HP:0002841) | 1.83763269 |
| 126 | Joint stiffness (HP:0001387) | 1.82625124 |
| 127 | Purpura (HP:0000979) | 1.81419681 |
| 128 | Obstructive lung disease (HP:0006536) | 1.78402776 |
| 129 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78402776 |
| 130 | Abnormality of glycolysis (HP:0004366) | 1.77069933 |
| 131 | Recurrent skin infections (HP:0001581) | 1.76667958 |
| 132 | Emotional lability (HP:0000712) | 1.76265368 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.76130532 |
| 134 | Progressive microcephaly (HP:0000253) | 1.75925802 |
| 135 | Abnormal platelet function (HP:0011869) | 1.75866423 |
| 136 | Impaired platelet aggregation (HP:0003540) | 1.75866423 |
| 137 | Hepatic necrosis (HP:0002605) | 1.75677531 |
| 138 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.75270660 |
| 139 | Upper limb amyotrophy (HP:0009129) | 1.75197342 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.75197342 |
| 141 | Insomnia (HP:0100785) | 1.74957704 |
| 142 | Generalized aminoaciduria (HP:0002909) | 1.74763638 |
| 143 | Increased serum pyruvate (HP:0003542) | 1.73593547 |
| 144 | Nausea (HP:0002018) | 1.72878899 |
| 145 | Abnormality of the vocal cords (HP:0008777) | 1.72574498 |
| 146 | Reduced antithrombin III activity (HP:0001976) | 1.72573538 |
| 147 | Spastic paraparesis (HP:0002313) | 1.72454592 |
| 148 | Ankle contracture (HP:0006466) | 1.71815525 |
| 149 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.71126077 |
| 150 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.70243738 |
| 151 | Abnormality of the Achilles tendon (HP:0005109) | 1.68703458 |
| 152 | Mitochondrial inheritance (HP:0001427) | 1.68014745 |
| 153 | Polycythemia (HP:0001901) | 1.67676845 |
| 154 | Papilloma (HP:0012740) | 1.67198402 |
| 155 | Verrucae (HP:0200043) | 1.67198402 |
| 156 | Carpal bone hypoplasia (HP:0001498) | 1.66418629 |
| 157 | Type I transferrin isoform profile (HP:0003642) | 1.66170582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.65066235 |
| 2 | TRIB3 | 3.51399439 |
| 3 | TESK2 | 3.44764196 |
| 4 | TESK1 | 3.40983031 |
| 5 | NME2 | 3.35045919 |
| 6 | ERN1 | 3.17321247 |
| 7 | IRAK3 | 3.14424777 |
| 8 | SCYL2 | 2.99706257 |
| 9 | KDR | 2.80759130 |
| 10 | ARAF | 2.71654693 |
| 11 | MAP3K11 | 2.45896426 |
| 12 | PKN2 | 2.39995953 |
| 13 | BUB1 | 2.31298115 |
| 14 | PIM2 | 2.28232052 |
| 15 | LIMK1 | 2.09735234 |
| 16 | MAP4K1 | 2.01555391 |
| 17 | BLK | 1.99284169 |
| 18 | NEK1 | 1.85142506 |
| 19 | MAP3K12 | 1.81960090 |
| 20 | ZAP70 | 1.65947735 |
| 21 | KSR2 | 1.62333641 |
| 22 | PBK | 1.56302216 |
| 23 | EPHA2 | 1.54225831 |
| 24 | TBK1 | 1.52432539 |
| 25 | ILK | 1.43899058 |
| 26 | LRRK2 | 1.42629056 |
| 27 | MAP3K9 | 1.41921651 |
| 28 | CAMKK1 | 1.41147282 |
| 29 | MAPKAPK3 | 1.38039464 |
| 30 | PAK4 | 1.33513785 |
| 31 | EPHB2 | 1.30410429 |
| 32 | CAMKK2 | 1.29383909 |
| 33 | DAPK3 | 1.28556052 |
| 34 | BRAF | 1.25390029 |
| 35 | TAOK1 | 1.24200247 |
| 36 | DAPK1 | 1.22314099 |
| 37 | BCKDK | 1.20691845 |
| 38 | EIF2AK1 | 1.19988966 |
| 39 | SMG1 | 1.18351672 |
| 40 | CDK19 | 1.16447469 |
| 41 | WEE1 | 1.13360080 |
| 42 | EEF2K | 1.12434697 |
| 43 | BRSK1 | 1.09260586 |
| 44 | MAP3K10 | 1.05423494 |
| 45 | MINK1 | 1.05409991 |
| 46 | DAPK2 | 1.04271308 |
| 47 | RPS6KA4 | 1.02004618 |
| 48 | MAP3K1 | 0.95752133 |
| 49 | PTK2 | 0.95243424 |
| 50 | PDK2 | 0.94930147 |
| 51 | MAP3K3 | 0.94453208 |
| 52 | LMTK2 | 0.92644495 |
| 53 | GRK6 | 0.92608280 |
| 54 | SYK | 0.88640095 |
| 55 | NEK2 | 0.88099224 |
| 56 | MAP3K8 | 0.88047189 |
| 57 | ABL2 | 0.85005902 |
| 58 | TGFBR2 | 0.83753639 |
| 59 | MAP2K6 | 0.82479190 |
| 60 | PAK1 | 0.81331408 |
| 61 | TYK2 | 0.81111644 |
| 62 | CSNK1G3 | 0.80675822 |
| 63 | JAK3 | 0.80183927 |
| 64 | VRK1 | 0.79738492 |
| 65 | ICK | 0.77626582 |
| 66 | STK16 | 0.74036382 |
| 67 | MAP2K3 | 0.72163646 |
| 68 | NTRK1 | 0.69805017 |
| 69 | EIF2AK3 | 0.69786496 |
| 70 | KIT | 0.68672618 |
| 71 | PRKG2 | 0.68459974 |
| 72 | MATK | 0.68075448 |
| 73 | AURKA | 0.65860142 |
| 74 | MAP2K2 | 0.64723835 |
| 75 | RAF1 | 0.63978328 |
| 76 | CDK14 | 0.63630230 |
| 77 | MAP2K7 | 0.61658047 |
| 78 | FLT3 | 0.61052571 |
| 79 | MAP2K1 | 0.59750180 |
| 80 | LATS2 | 0.59687573 |
| 81 | DMPK | 0.59581655 |
| 82 | BTK | 0.59063551 |
| 83 | ALK | 0.57871353 |
| 84 | CDK15 | 0.54114558 |
| 85 | CDK18 | 0.53950130 |
| 86 | CDK11A | 0.53548106 |
| 87 | GRK7 | 0.53495745 |
| 88 | CDK8 | 0.53185663 |
| 89 | CAMK2G | 0.53024786 |
| 90 | TLK1 | 0.52698077 |
| 91 | ERBB4 | 0.51608878 |
| 92 | MST1R | 0.51211777 |
| 93 | BMX | 0.50440529 |
| 94 | CCNB1 | 0.49607984 |
| 95 | PRKD3 | 0.48799100 |
| 96 | IKBKB | 0.47300497 |
| 97 | CSNK1A1L | 0.47087743 |
| 98 | RET | 0.46720417 |
| 99 | DDR2 | 0.46651445 |
| 100 | IRAK4 | 0.46301384 |
| 101 | GRK5 | 0.45495760 |
| 102 | TGFBR1 | 0.44836721 |
| 103 | AURKB | 0.44624562 |
| 104 | RIPK4 | 0.43803282 |
| 105 | SIK3 | 0.43326415 |
| 106 | MAP3K2 | 0.43265080 |
| 107 | MARK1 | 0.41888277 |
| 108 | CSNK1G2 | 0.41767897 |
| 109 | DYRK3 | 0.41360125 |
| 110 | RPS6KA2 | 0.40814451 |
| 111 | CDK7 | 0.40615261 |
| 112 | TTN | 0.40397358 |
| 113 | PRKCD | 0.40375157 |
| 114 | AKT2 | 0.39669535 |
| 115 | PRKCI | 0.39570383 |
| 116 | JAK2 | 0.39061437 |
| 117 | PLK1 | 0.38894370 |
| 118 | BRSK2 | 0.38564337 |
| 119 | RPS6KB2 | 0.38337314 |
| 120 | CHEK2 | 0.38244692 |
| 121 | CDC7 | 0.38025197 |
| 122 | STK10 | 0.35433849 |
| 123 | NEK9 | 0.34539971 |
| 124 | SIK1 | 0.33925548 |
| 125 | PAK2 | 0.33823668 |
| 126 | NME1 | 0.33560143 |
| 127 | RPS6KA5 | 0.33510205 |
| 128 | PIM1 | 0.33225078 |
| 129 | MYLK | 0.32776115 |
| 130 | MAP3K13 | 0.31834456 |
| 131 | TAOK2 | 0.31770630 |
| 132 | SIK2 | 0.31531246 |
| 133 | STK4 | 0.31412044 |
| 134 | CSNK2A1 | 0.31179512 |
| 135 | IRAK2 | 0.30924544 |
| 136 | MAP3K5 | 0.30359515 |
| 137 | DYRK2 | 0.30155912 |
| 138 | MOS | 0.30126080 |
| 139 | PAK6 | 0.29110944 |
| 140 | PRPF4B | 0.28329991 |
| 141 | CSNK1G1 | 0.28078961 |
| 142 | CSNK2A2 | 0.26617984 |
| 143 | ZAK | 0.26145708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.41264389 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.07539313 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.44461581 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.17027660 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.02959212 |
| 6 | Shigellosis_Homo sapiens_hsa05131 | 1.89224144 |
| 7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.87549572 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.81154542 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 1.75723089 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75642332 |
| 11 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.73601097 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.71083800 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.65481175 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65380348 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63124827 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62552918 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.58402123 |
| 18 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.51221014 |
| 19 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50244071 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47507698 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47251429 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.45223464 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44833539 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 1.40409058 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.39336620 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38565848 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37201152 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.34549809 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34403929 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30696710 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.29037573 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25667064 |
| 33 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.25550893 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24271662 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23890398 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.21272776 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21234772 |
| 38 | RNA polymerase_Homo sapiens_hsa03020 | 1.20441825 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20231258 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.17625326 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15680560 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.15435812 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15223728 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11269143 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10659538 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10336869 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10314214 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09667207 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08018217 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 1.07239381 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03811855 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03583705 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02398298 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.95784820 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91083512 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89004052 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85631353 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.84885549 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83554487 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.83197997 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82474557 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.80363634 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79683682 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79638688 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79048888 |
| 66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78940768 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78659307 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78365087 |
| 69 | * Endocytosis_Homo sapiens_hsa04144 | 0.77898139 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77096669 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76514793 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75401308 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75338268 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75275143 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74703133 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.74046444 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73795344 |
| 78 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.73481898 |
| 79 | RNA transport_Homo sapiens_hsa03013 | 0.73026311 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71216361 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71181627 |
| 82 | Protein export_Homo sapiens_hsa03060 | 0.70766218 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.69549566 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69194988 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65625377 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64932901 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64778101 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64482310 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62479472 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.60566004 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.60228694 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57896011 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57723914 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56555017 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56515414 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55692416 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.55248788 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.54232426 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53913891 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53173333 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51411845 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48679127 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48356520 |
| 104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47022760 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46876242 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45661072 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.44414751 |
| 108 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44240821 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43754357 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43616360 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43317074 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.42455024 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42250819 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41335052 |
| 115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41249836 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38696845 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36290919 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34945242 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33556717 |
| 120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32133760 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29614962 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29118012 |
| 123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28212286 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.24796262 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.23492960 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.21507297 |
| 127 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19764181 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19422564 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16080208 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.14157602 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.13874337 |

